The ROS level was reduced, and ROS/NF-κB signaling pathway was inhibited by lncRNA XIST knockdown via miR-103a-3p/HMGB1 axis, which could attenuate IL-1β-induced dysfunction of HUVECs to reduce the risk of DVT. The gene discussed is HMGB1; the disease is deep vein thrombosis.